Pertuzumab Is an Essential Therapy Option for HER2-Positive Breast Cancer Patients
Pertuzumab is a monoclonal antibody drug that is used in the treatment of breast cancer, specifically HER2-positive breast cancer. It is marketed under the brand name Perjeta and is developed and manufactured by the pharmaceutical company Genentech. Pertuzuma works by targeting the HER2 protein, which is overexpressed in about 25% of breast cancers. By binding to the HER2 protein, Pertuzuma prevents the protein from signaling cancer cells to grow and divide, which can slow or stop the growth of the cancer.
Pertuzumab is typically used in combination with other cancer treatments, such as chemotherapy and trastuzumab, to achieve the best possible results. The combination of Pertuzuma and trastuzumab has been shown to be particularly effective in the treatment of HER2-positive breast cancer. Pertuzuma is usually given intravenously, which means that it is administered through a vein in the patient's arm. The drug is typically given once every three weeks, in combination with other cancer treatments, for a total of six to eight cycles.
According to Coherent Market Insights the Pertuzumab Market Size, Share, Outlook, and Opportunity Analysis, 2022-2028.
Adjuvant therapy: Pertuzumab may be used as an adjuvant therapy, which means that it is used in addition to primary treatment, such as surgery or radiation therapy, to reduce the risk of cancer recurrence. This is especially important for patients with early-stage HER2-positive breast cancer, as it can help prevent the cancer from returning. Metastatic breast cancer: Pertuzuma may be used in the treatment of metastatic breast cancer, which means that the cancer has spread to other parts of the body. In these cases, Pertuzuma is used in combination with other cancer treatments to slow the progression of the disease and improve quality of life for the patient.
In conclusion, Pertuzumab is an important treatment option for patients with HER2-positive breast cancer. While it is not appropriate for everyone, it can be a powerful tool in the fight against cancer when used in the right setting and in combination with other cancer treatments. Patients should work closely with their doctors to determine the best treatment plan for their specific type and stage of breast cancer.
Comments
Post a Comment